CIK 0001653087
- Accelerated filer
- Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 822933343
- Phone
- +1 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,087
- in 3 filings
Net −$296,087. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-12-23 | ORBIMED ADVISORS LLC 10% owner | Sale | −20,350 | $19.82 | $403K | 2,668,582 |
| 2019-12-23 | ORBIMED ADVISORS LLC 10% owner | Sale | −10,400 | $19.82 | $206K | 49,400 |
| 2019-12-20 | ORBIMED ADVISORS LLC 10% owner | Sale | −230,721 | $19.66 | $4.5M | 8,398,697 |
| 2019-12-20 | ORBIMED ADVISORS LLC 10% owner | Sale | −73,879 | $19.66 | $1.5M | 2,688,932 |
| 2019-12-20 | ORBIMED ADVISORS LLC 10% owner | Sale | −37,900 | $19.66 | $745K | 59,800 |
| 2019-12-17 | ORBIMED ADVISORS LLC 10% owner | Sale | −642,807 | $18.52 | $11.9M | 8,629,418 |
| 2019-12-17 | ORBIMED ADVISORS LLC 10% owner | Sale | −205,793 | $18.52 | $3.8M | 2,762,811 |
| 2019-12-17 | ORBIMED ADVISORS LLC 10% owner | Sale | −105,500 | $18.52 | $2.0M | 97,700 |
| 2019-12-13 | Paul Robert Chief Medical Officer | Sale | −10,000 | $20.03 | $200K | 283,719 |
| 2019-12-12 | Oney Sabah Chief Business Officer | Sale | −6,810 | $20.13 | $137K | 593,918 |
| 2019-12-10 | Oney Sabah Chief Business Officer | Sale | −500 | $20.01 | $10K | 593,918 |
| 2019-12-09 | Oney Sabah Chief Business Officer | Sale | −2,300 | $20.07 | $46K | 593,918 |
| 2019-12-06 | Oney Sabah Chief Business Officer | Sale | −5,156 | $20.02 | $103K | 593,918 |
| 2019-12-05 | Oney Sabah Chief Business Officer | Sale | −1,500 | $20.00 | $30K | 593,918 |
| 2019-12-03 | Yu Calvin Vice President, Finance | Sale | −1,315 | $18.31 | $24K | 175,294 |
| 2019-11-15 | King Robert Chief Development Officer | Sale | −7,500 | $15.92 | $119K | 522,317 |
| 2019-11-15 | Paul Robert Chief Medical Officer | Sale | −10,000 | $15.93 | $159K | 293,719 |
| 2019-10-15 | Paul Robert Chief Medical Officer | Sale | −10,000 | $14.68 | $147K | 301,719 |
| 2019-09-20 | Oney Sabah Chief Business Officer | Sale | −400 | $20.00 | $8K | 593,918 |
| 2019-09-20 | Paul Robert Chief Medical Officer | Sale | −4,000 | $20.00 | $80K | 311,719 |
Page 12 of 13 · 249 trades